I've watched this happen too many times now. A stock stagnates in the winter of investor apathy only to shoot up suddenly like the tendrils of a tulip in spring. By then of course, it's too late. Your inattention has cost you a fortune. But before I explain why this is the case with Cyclacel (CYCC) Pharmaceuticals allow me to give you two recent examples from my portfolio that illustrate why this phenomenon occurs in the first place.
Example 1: A Misunderstood Science Fosters Buyer Indecision - Sunshine Heart (SSH)
From April 23rd to July 1st, Sunshine Heart stagnated at just over $5.00 a share. During that time some of the best authors on Seeking Alpha...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|